MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $54.36
1.46 (2.76%) Open Price: 53.27

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(09/15/25) $53.27
(09/16/25) $52.90
(09/16/25) (Qty.)774,746
(09/15/25) $51.45
(09/15/25) $53.87
(04/06/25) $31.42
(08/31/25) $61.87
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing